Diagnosis and biomarkers of predementia in Alzheimer's disease. (Q33777509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

2 references

19 November 2020

Diagnosis and biomarkers of predementia in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

19 November 2020

3 references

25 April 2019

19 June 2019

19 November 2020

3 references

25 April 2019

19 June 2019

19 November 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

Wagner F Gattaz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Orestes V Forlenza

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

22 December 2010

4 references

25 April 2019

19 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

19 November 2020

4 references

25 April 2019

19 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

19 November 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

18 January 2020

copyright license

3 references

25 April 2019

19 June 2019

19 November 2020

0 references

on focus list of Wikimedia project

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1741-7015-8-89

0 references

cites work

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Alzheimer's disease: strategies for disease modification

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Forecasting the global burden of Alzheimer’s disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Frequent amyloid deposition without significant cognitive impairment among the elderly

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Voxel-based morphometry in Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Worldwide variation in the doubling time of Alzheimer's disease incidence rates

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Mild cognitive impairment and everyday function: evidence of reduced speed in performing instrumental activities of daily living

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Characterization of activities of daily living in individuals with mild cognitive impairment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Early cognitive change in the general population: how do different definitions work?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Beta-amyloid burden is not associated with rates of brain atrophy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

PET imaging of amyloid deposition in patients with mild cognitive impairment.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Neuropathologic features of amnestic mild cognitive impairment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Mild cognitive impairment as a diagnostic entity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Is MCI really just early dementia? A systematic review of conversion studies.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

CSF markers for incipient Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Sequence of Abeta-protein deposition in the human medial temporal lobe.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Mild cognitive impairment: clinical characterization and outcome

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Neuropathology of cognitively normal elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Short-term memory binding deficits in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Diagnostic transitions in mild cognitive impairment subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Conversion from subtypes of mild cognitive impairment to Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Functional abilities in older adults with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Dynamics of brain-derived proteins in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Principal component analysis of FDG PET in amnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Detection of prodromal Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Detection of amyloid-beta oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

MCI is a clinically useful concept.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022870

Assessment of cognitive impairment and dementia using informant reports

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-89

Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment

21 January 2018

1 reference

12 December 2020

Mild cognitive impairment: a concept ready to move on?

1 reference

12 December 2020

Stability of neurocognitive impairment in different subtypes of mild cognitive impairment

1 reference

12 December 2020

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

12 December 2020

Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment

1 reference

12 December 2020

Biomarkers: principles, policies, and practice

1 reference

12 December 2020

Mild cognitive impairment: long-term course of four clinical subtypes

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-8-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176189%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference